tradingkey.logo
tradingkey.logo
Search

Aclaris Therapeutics Inc

ACRS
Add to Watchlist
5.250USD
+0.050+0.96%
Close 07-31 16:00ETQuotes delayed by 15 min
733.18MMarket Cap
LossP/E TTM

Institutional Confidence

Currency: USD Updated: 2026-07-31
Previous score
7.00
Change
0
The current institutional shareholding score of Aclaris Therapeutics Inc is 7.00, ranking 80 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 72.75%, representing a quarter-over-quarter decrease of 32.53%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.36% of shares outstanding, with 0.03% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name
Shares Held
Chg %
BML Capital Management LLC
14.25M
--
Deep Track Capital LP
9.35M
--
Vivo Capital, LLC
8.89M
--
BlackRock Institutional Trust Company, N.A.
6.12M
+19.22%
Rock Springs Capital Management LP
4.45M
-3.38%
Decheng Capital LLC
4.04M
--
Adage Capital Management, L.P.
3.37M
-36.13%
Geode Capital Management, L.L.C.
2.39M
+0.14%
1
2
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.